Metropolitan Life Insurance CO Moderna, Inc. Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

54 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $10,500 - $14,199	-123 Reduced 0.91%	13,378 $1.43 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $13,762 - $20,677	-198 Reduced 1.45%	13,501 $1.34 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $56,689 - $74,446	-588 Reduced 4.12%	13,699 $1.41 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $58,065 - $78,659	-490 Reduced 3.32%	14,287 $1.74 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $482,542 - $700,800	-3,557 Reduced 19.4%	14,777 $2.27 Million
Q4 2022 Jun 14, 2023	BUY	$118.38 - $210.04 $421,077 - $747,112	3,557 Added 24.07%	18,334 $3.29 Billion
Q4 2022 Mar 30, 2023	SELL	$118.38 - $210.04 $116,485 - $206,679	-984 Reduced 5.09%	18,334 $3.29 Million
Q4 2022 Feb 15, 2023	SELL	$118.38 - $210.04 $116,485 - $206,679	-984 Reduced 5.09%	18,334 $3.29 Million
Q3 2022 Jun 14, 2023	BUY	$118.07 - $194.18 $536,155 - $881,771	4,541 Added 30.73%	19,318 $2.28 Billion
Q3 2022 Mar 30, 2023	SELL	$118.07 - $194.18 $93,983 - $154,567	-796 Reduced 3.96%	19,318 $2.28 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $93,983 - $154,567	-796 Reduced 3.96%	19,318 $2.28 Million
Q2 2022 Jun 20, 2023	BUY	$117.13 - $176.59 $625,122 - $942,460	5,337 Added 36.12%	20,114 $2.87 Million
Q2 2022 Mar 30, 2023	SELL	$117.13 - $176.59 $107,056 - $161,403	-914 Reduced 4.35%	20,114 $2.87 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $107,056 - $161,403	-914 Reduced 4.35%	20,114 $2.87 Million
Q1 2022 Jun 20, 2023	BUY	$126.46 - $235.05 $790,501 - $1.47 Million	6,251 Added 42.3%	21,028 $3.62 Million
Q1 2022 Mar 30, 2023	SELL	$126.46 - $235.05 $4.31 Million - $8 Million	-34,053 Reduced 61.82%	21,028 $3.62 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $4.31 Million - $8 Million	-34,053 Reduced 61.82%	21,028 $3.62 Million
Q4 2021 Jun 21, 2023	BUY	$225.82 - $368.51 $9.1 Million - $14.9 Million	40,304 Added 272.75%	55,081 $14 Million
Q4 2021 Mar 30, 2023	SELL	$225.82 - $368.51 $339,407 - $553,870	-1,503 Reduced 2.66%	55,081 $14 Million
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $339,407 - $553,870	-1,503 Reduced 2.66%	55,081 $14 Million
Q3 2021 Jun 21, 2023	BUY	$221.9 - $484.47 $9.28 Million - $20.3 Million	41,807 Added 282.92%	56,584 $21.8 Million
Q3 2021 Mar 30, 2023	BUY	$221.9 - $484.47 $7.35 Million - $16 Million	33,128 Added 141.23%	56,584 $21.8 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $7.35 Million - $16 Million	33,128 Added 141.23%	56,584 $21.8 Million
Q2 2021 Jun 21, 2023	BUY	$129.91 - $234.98 $1.13 Million - $2.04 Million	8,679 Added 58.73%	23,456 $5.51 Million
Q2 2021 Mar 30, 2023	BUY	$129.91 - $234.98 $350,107 - $633,271	2,695 Added 12.98%	23,456 $5.51 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $3.04 Million - $5.51 Million	23,435 Added 111595.24%	23,456 $5.51 Million
Q1 2021 Jun 26, 2023	BUY	$109.18 - $185.98 $653,333 - $1.11 Million	5,984 Added 40.5%	20,761 $2.72 Billion
Q1 2021 Mar 30, 2023	SELL	$109.18 - $185.98 $101,974 - $173,705	-934 Reduced 4.31%	20,761 $2.72 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $2.37 Million - $4.03 Million	-21,674 Reduced 99.9%	21 $2.72 Million
Q4 2020 Jun 22, 2023	BUY	$65.74 - $169.86 $454,789 - $1.18 Million	6,918 Added 46.82%	21,695 $2.27 Million
Q4 2020 Mar 30, 2023	SELL	$65.74 - $169.86 $27,808 - $71,850	-423 Reduced 1.91%	21,695 $2.27 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $27,808 - $71,850	-423 Reduced 1.91%	21,695 $2.27 Million
Q3 2020 Jun 26, 2023	BUY	$54.34 - $94.85 $398,909 - $696,293	7,341 Added 49.68%	22,118 $1.56 Million
Q3 2020 Mar 30, 2023	BUY	$54.34 - $94.85 $41,841 - $73,034	770 Added 3.61%	22,118 $1.56 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $41,841 - $73,034	770 Added 3.61%	22,118 $1.57 Million
Q2 2020 Jun 26, 2023	BUY	$29.67 - $80.0 $194,961 - $525,680	6,571 Added 44.47%	21,348 $1.37 Million
Q2 2020 Mar 30, 2023	BUY	$29.67 - $80.0 $199,085 - $536,800	6,710 Added 45.84%	21,348 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $199,085 - $536,800	6,710 Added 45.84%	21,348 $1.37 Million
Q1 2020 Jul 12, 2023	SELL	$17.78 - $31.58 $2,471 - $4,389	-139 Reduced 0.94%	14,638 $438,000
Q1 2020 Mar 30, 2023	BUY	$17.78 - $31.58 $11,717 - $20,811	659 Added 4.71%	14,638 $438,000
Q1 2020 May 15, 2020	BUY	$17.78 - $31.58 $11,717 - $20,811	659 Added 4.71%	14,638 $438,000
Q4 2019 Jul 12, 2023	SELL	$13.93 - $21.28 $11,116 - $16,981	-798 Reduced 5.4%	13,979 $273,000
Q4 2019 Mar 30, 2023	SELL	$13.93 - $21.28 $933 - $1,425	-67 Reduced 0.48%	13,979 $273,000
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $933 - $1,425	-67 Reduced 0.48%	13,979 $273,000
Q3 2019 Jul 12, 2023	SELL	$12.26 - $18.07 $8,962 - $13,209	-731 Reduced 4.95%	14,046 $223,000
Q3 2019 Mar 30, 2023	BUY	$12.26 - $18.07 $149,976 - $221,050	12,233 Added 674.74%	14,046 $223,000
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $149,976 - $221,050	12,233 Added 674.74%	14,046 $224,000
Q2 2019 Jul 12, 2023	SELL	$13.7 - $28.34 $177,606 - $367,399	-12,964 Reduced 87.73%	1,813 $26,000
Q2 2019 Mar 30, 2023	SELL	$13.7 - $28.34 $548 - $1,133	-40 Reduced 2.16%	1,813 $26,000
Q2 2019 Aug 14, 2019	SELL	$13.7 - $28.34 $548 - $1,133	-40 Reduced 2.16%	1,813 $27,000
Q1 2019 Jul 13, 2023	SELL	$14.45 - $23.7 $186,751 - $306,298	-12,924 Reduced 87.46%	1,853 $37,000
Q1 2019 Mar 30, 2023	SELL	$14.45 - $23.7 $238,150 - $390,599	-16,481 Reduced 89.89%	1,853 $37,000
Q1 2019 May 16, 2019	SELL	$14.45 - $23.7 $1.78 Million - $2.92 Million	-123,002 Reduced 98.52%	1,853 $37,000
Q1 2019 May 15, 2019	BUY	$14.45 - $23.7 $1.8 Million - $2.96 Million	124,855 New	124,855 $9.28 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account